AGER and cancer: Hence multiple research studies including clinical trials (as shown in Tables 2 and 3) are underway to unravel the substantial concomitance of glycation triad—AGEs, sRAGE and RAGE, as potent diagnostic and therapeutic biomarkers with translational significance in cancer.